Among these networks, the PI3K/Akt/mTOR axis appears especially promising for therapeutic intervention, as it integrates signals from multiple HCC pathways that regulate proliferation, survival, and drug resistance. This evidence concerns the gene MTOR and hepatocellular carcinoma.